» Articles » PMID: 11705562

Intake of Vitamin D and Risk of Type 1 Diabetes: a Birth-cohort Study

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2001 Nov 14
PMID 11705562
Citations 496
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dietary vitamin D supplementation is associated with reduced risk of type 1 diabetes in animals. Our aim was to ascertain whether or not vitamin D supplementation or deficiency in infancy could affect development of type 1 diabetes.

Methods: A birth-cohort study was done, in which all pregnant women (n=12055) in Oulu and Lapland, northern Finland, who were due to give birth in 1966 were enrolled. Data was collected in the first year of life about frequency and dose of vitamin D supplementation and presence of suspected rickets. Our primary outcome measure was diagnosis of type 1 diabetes by end of December, 1997.

Findings: 12058 of 12231 represented live births, and 10821 (91% of those alive) children were followed-up at age 1 year. Of the 10366 children included in analyses, 81 were diagnosed with diabetes during the study. Vitamin D supplementation was associated with a decreased frequency of type 1 diabetes when adjusted for neonatal, anthropometric, and social characteristics (rate ratio [RR] for regular vs no supplementation 0.12, 95% CI 0.03-0.51, and irregular vs no supplementation 0.16, 0.04-0.74. Children who regularly took the recommended dose of vitamin D (2000 IU daily) had a RR of 0.22 (0.05-0.89) compared with those who regularly received less than the recommended amount. Children suspected of having rickets during the first year of life had a RR of 3.0 (1.0-9.0) compared with those without such a suspicion.

Interpretation: Dietary vitamin D supplementation is associated with reduced risk of type 1 diabetes. Ensuring adequate vitamin D supplementation for infants could help to reverse the increasing trend in the incidence of type 1 diabetes.

Citing Articles

Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines.

Grant W, Wimalawansa S, Pludowski P, Cheng R Nutrients. 2025; 17(2).

PMID: 39861407 PMC: 11767646. DOI: 10.3390/nu17020277.


The Colonic Vitamin D Receptor and Inflammatory Bowel Disease: No Correlation to Histologic or Endoscopic Inflammation.

Bagger-Jorgensen H, Thomsen C, Borrisholt M, Wanders A, Sjoberg K APMIS. 2025; 133(1):e70000.

PMID: 39829252 PMC: 11744339. DOI: 10.1111/apm.70000.


The vitamin D receptor TaqI TT genotype is associated with type 1 diabetes in the Black South African population.

Bhola S, Cave E, Prigge K, Bhana S, Crowther N, Padoa C J Nutr Sci. 2024; 13:e73.

PMID: 39703896 PMC: 11658941. DOI: 10.1017/jns.2024.77.


Vitamin D Supplementation as a Therapeutic Strategy in Autoimmune Diabetes: Insights and Implications for LADA Management.

Mourelatou N, Kounatidis D, Jude E, Rebelos E Nutrients. 2024; 16(23).

PMID: 39683465 PMC: 11643312. DOI: 10.3390/nu16234072.


Unveiling the Interplay-Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2.

Wimalawansa S Biology (Basel). 2024; 13(10).

PMID: 39452140 PMC: 11504239. DOI: 10.3390/biology13100831.